Rhumbline Advisers Ocugen, Inc. Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in Ocugen, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 9,593 shares of OCGN stock, worth $15,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,593
Previous 9,593
-0.0%
Holding current value
$15,732
Previous $5,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding OCGN
# of Institutions
88Shares Held
32.8MCall Options Held
518KPut Options Held
345K-
Vanguard Group Inc Valley Forge, PA12MShares$19.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.8MShares$6.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$5.27 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$4.28 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.93MShares$3.16 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $355M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...